ENGN – engene holdings inc. (US:NASDAQ)

News

Combination Therapies Reshape Oncology: A $748B Market Shifts Standard of Care
enGene Highlights 2026 Data Catalysts, BLA Plans for Bladder Cancer Gene Therapy at Barclays Conference [Yahoo! Finance]
enGene CEO Pitches Detalimogene as Community-Friendly NMIBC Option, Teases Q2 LEGEND Data Update [Yahoo! Finance]
enGene (ENGN) was upgraded by Wall Street Zen from "sell" to "hold".
enGene Holdings: Key Catalysts Incoming For 2026 [Seeking Alpha]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com